Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 4 of the 12 sources its claims cite were checked for support.
Abstract
Common recommendations for cell line authentication, annotation and quality control fall short addressing genetic heterogeneity. Within the Human Toxome Project, we demonstrate that there can be marked cellular and phenotypic heterogeneity in a single batch of the human breast adenocarcinoma cell line MCF-7 obtained directly from a cell bank that are invisible with the usual cell authentication by short tandem repeat (STR) markers. STR profiling just fulfills the purpose of authentication testing, which is to detect significant cross-contamination and cell line misidentification. Heterogeneity needs to be examined using additional methods. This heterogeneity can have serious consequences for reproducibility of experiments as shown by morphology, estrogenic growth dose-response, whole genome gene expression and untargeted mass-spectroscopy metabolomics for MCF-7 cells. Using Comparative Genomic Hybridization (CGH), differences were traced back to genetic heterogeneity already in the cells from the original frozen vials from the same ATCC lot, however, STR markers did not differ from ATCC reference for any sample. These findings underscore the need for additional quality assurance in Good Cell Culture Practice and cell characterization, especially using other methods such as CGH to reveal possible genomic heterogeneity and genetic drifts within cell lines.
Overview
CoChat Summary
TL;DR
MCF-7 cells from the same ATCC lot and with matching STR profiles showed marked phenotypic, transcriptomic, metabolomic, and genomic heterogeneity between two laboratories. This heterogeneity was already present in DNA from original frozen vials and affected key functional outcomes such as estradiol-driven proliferation.
Key findings
- Two laboratories (BU and JHU) using MCF-7 from the same ATCC lot (lot 59388743, passage 147) and identical STR profiles for all 9 typed markers observed different phenotypes: BU cells grew in large aggregations, while JHU cells grew flat with cobblestone morphology.
- After 72 h exposure to estradiol, BU MCF-7 cells showed significant increases in proliferation at 0.1, 1, and 10 nM, whereas JHU cells showed no significant change; PPT exposure similarly increased proliferation in BU cells at 0.1, 1.0, and 10 nM but not in JHU cells.
- Untargeted metabolomics PCA of 1048 features separated the two sublines and showed differential response to E2; microarray PCA showed transcriptional differences already in untreated control cells, and an 84-gene heat map clustered the sublines separately.
- CGH detected almost the same significant genomic differences on chromosomes 1, 3, 4, 5, 7, 8, 9, 10, 13, 15, 20, and X in DNA directly prepared from two original never-thawed ATCC vials from the same lot as after a few passages in culture, while STR markers did not differ from the ATCC reference for any sample.
Methods
- MCF-7 cells from the same ATCC lot were obtained by Brown University and Johns Hopkins University; one vial per lab was grown using identical protocols and Good Cell Culture Practice, with experiments performed at passage 3 (BU) and passage 8 (JHU), while a second vial per lab remained never thawed.
- Assays included morphologic high-content imaging, estradiol/PPT proliferation and qRT-PCR for progesterone receptor, Agilent whole-genome gene expression microarrays, untargeted LC-MS metabolomics, Comparative Genomic Hybridization (CGH), and STR profiling.
- Analyses included two-way ANOVA, principal component analysis, unsupervised hierarchical clustering, and CGH aberration detection with ADM-2 threshold 10; CGH and STR experiments were performed in one laboratory by one individual.
Limitations
- The paper does not state a dedicated limitations section; it acknowledges that current authentication methods do not preclude genetic heterogeneity and that combining omics technologies does not overcome the limitations of tumor cell lines.
- Evident from the text: the study compares only two laboratories and one ATCC lot of MCF-7, so the generalizability to other cell lines, lots, or laboratories is not directly tested, although the authors suggest MCF-7 is likely not unique.
- Some verification experiments are reported only as “data not shown” (cells exchanged between laboratories), limiting independent assessment of those results.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
4 Valid · 1 Not valid · 2 Not checked · 31 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In this respect, MCF-7 are likely not unique. For example, studies with T47D - the second most commonly used cell line as an in vitro breast cancer model - as well as others20 suggest similar genotypic and phenotypic heterogeneity212223.”
§ Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function > Discussion
What the sources say
- Partly supportedcites [20] Rondon-Lagos M. et al. Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis. Molecular cytogenetics 7, 8 (2014). 24456987 PMC3914704 sourceExperimental — accuracy not yet measured
The Results section on T47D cells (page unavailable) reports variation in chromosomal abnormalities among its 24 metaphases, supporting the point that cytogenetic heterogeneity is not unique to MCF-7. It does not establish phenotypic heterogeneity within T47D, which the citing sentence also attributes to the cited studies. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [21] Graham M. L. 2nd, Smith J. A., Jewett P. B. & Horwitz K. B. Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry. Cancer Res 52, 593– 602 (1992). 1732047
- Not checked — no full text of the sourcecites [22] Hughes P., Marshall D., Reid Y., Parkes H. & Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? BioTechniques 43, 575, 577–578, 581–572 passim (2007). 18072586 source
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, studies with T47D - the second most commonly used cell line as an in vitro breast cancer model - as well as others20 suggest similar genotypic and phenotypic heterogeneity212223.”
§ Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function > Discussion
What the sources say
- Partly supportedcites [20] Rondon-Lagos M. et al. Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis. Molecular cytogenetics 7, 8 (2014). 24456987 PMC3914704 sourceExperimental — accuracy not yet measured
The Results section on T47D reports chromosomal alterations that vary among its metaphases, and the comparison of four cell lines reports distinct chromosomal patterns. These support genotypic heterogeneity, but the paper does not demonstrate phenotypic heterogeneity within T47D or the other cell lines. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [21] Graham M. L. 2nd, Smith J. A., Jewett P. B. & Horwitz K. B. Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry. Cancer Res 52, 593– 602 (1992). 1732047
- Not checked — no full text of the sourcecites [22] Hughes P., Marshall D., Reid Y., Parkes H. & Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? BioTechniques 43, 575, 577–578, 581–572 passim (2007). 18072586 source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This heterogeneity can have serious consequences for reproducibility of experiments as shown by morphology, estrogenic growth dose-response, whole genome gene expression and untargeted mass-spectroscopy metabolomics for MCF-7 cells.”
- Also stated in: § Discussion · plain
“Even simple outcomes, such as estradiol dose-response, can be divergent between two laboratories using what appear to be the “same” cells and the same protocol.”
§ Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Gene expression analysis using quantitative PCR of the estrogen receptor target progesterone receptor (PgR) following 6 hours of exposure to E2 indicated that BU MCF-7 cells are responsive to low levels of estrogen (Fig. 1C).”
§ Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function > Results
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Technical replicates of MCF-7 genomic DNA from MCF-7 cells being used for experiments after a few passages hybridized against human Caucasian female reference DNA showed only small differences of short length, which are simply expected by statistical chance because of the >100,000 involved CGH probes (Fig. 5).”
§ Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function > Results
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
7 more claims
Create a free account to see all 38 claims and every source verdict.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Systematic investigations revealed significant genetic differences in widely applied cell models between different laboratories (Frattini et al., 2015; Kleensang et al., 2016; Gutbier et al., 2018).”
From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Kleensang et al., 2016
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Pluskal, T., Castillo, S., Villar-Briones, A., & Orešič, M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-395 · Cited by 3,845
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
The Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
Hughes, P., Marshall, D., Reid, Y., Parkes, H., & Gelber, C. (2007) · BioTechniques · doi:10.2144/000112598 · Cited by 434
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371
A resource for cell line authentication, annotation and quality control
Yu, M., Selvaraj, S. K., Liang-Chu, M. M. Y., Aghajani, S., Busse, M., Yuan, J., Lee, G., Peale, F., Klijn, C., Bourgon, R., et al. (2015) · Nature · doi:10.1038/nature14397 · Cited by 225
Cited by
Items 101–109 of 109
Comprehensive and realistic simulation of tumour genomic sequencing data
O'Sullivan, B. P., & Seoighe, C. (2023) · NAR Cancer · doi:10.1093/narcan/zcad051
“As a consequence, these simulation meth-ods do not provide an accurate and complete set of the true soma tic muta tions in the sample ( 24 , 25 ).”
BackgroundKohler, M., Krämer, M., Draphoen, B., Schmitt, F., Lindén, M., Kissmann, A., Ziener, U., & Rosenau, F. (2024) · Applied Sciences · doi:10.3390/app14209151
Maertens, A., & Härtung, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15742-4.00098-3 · Cited by 1
Self-citationIntegration of hyperspectral imaging and transcriptomics from individual cells with SpectralSeq
Xie, Y., Habibalahi, A., Anwer, A. G., Wahi, K., Bailey, J., Lin, F., Gatt, C., Johansson, E. M. V., Chtanova, T., Holst, J., et al. (2025) · Genome Research · doi:10.1101/gr.280014.124 · Cited by 1
“…would benefit biomedical applications including cancer and infectious disease, given that both malignant and virus-infected cells can be genetically (Kleensang et al. 2016), transcriptionally (Zanini et al. 2018), and metabolically (Guillaume-Gentil et al. 2017) diverse within a single culture.”
Substantial genomic and methylation variability between MCF-7 sublinesPreprint
Atanda, H. C., & Ewing, A. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.17.706500
“…culture conditions of MCF-7 cells across research groups and laboratories have led to the emergence of sublines with different proliferation and differentiation rates, affecting research reproducibility and clinical translation (Kleensang et al., 2016; Nugoli et al., 2003; Osborne et al., 1987).”
Epigenetic regulation by estrogen receptor in breast cancer cells
Sklias, A. (2019) · theses.fr (ABES) · doi:10.70675/8537438cz506dz47b5z91b1z111daf18658a · Cited by 1
“The origin of the MCF-7 cell line, the composition of growth medium, the quality of charcoal stripping of serum, the duration of E2-deprivation or the E2 concentration used for re-stimulation, are some examples that can affect the estrogenic growth doseresponse and hence contribute to reproducibility issues (Kleensang…”
BackgroundResultApplications in Modern Research
Badal, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-28873-8_6
Korch, C. T., Capes-Davis, D., & Shen, C. (2026) · Current Protocols · doi:10.1002/cpz1.70439 · Cited by 1
Metadata
- Authors
- Kleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H.-H., Livi, C. B., Madnick, S., Maertens, A., Rosenberg, M., Yager, J. D., Zhao, L., & Hartung, T.
- Affiliations
- Brown University (US)
- Johns Hopkins University (US)
- The Hamner Institutes for Health Sciences (US)
- Georgetown University (US)
- Agilent Technologies (United States) (US)
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-07-26
- Volume
- 6
- Issue
- 1
- Pages
- 28994-28994
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4960662
- OpenAlex
- W2493132014
- Cited by
- 114
- References
- 28
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 14 · 2020: 11 · 2019: 16 · 2018: 26 · 2017: 15 · 2016: 3
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-09-14)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KOPS (University of Konstanz) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (R01ES020750)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- MCF-7 cells, cell line authentication, genetic heterogeneity, short tandem repeat profiling, comparative genomic hybridization, genomic heterogeneity, genetic drift, gene expression profiling, metabolomics, reproducibility
- MeSH terms
- Genetic Markers, Humans, Genetic Variation, Reproducibility of Results, Microsatellite Repeats, Gene Expression Profiling, Cell Line, Tumor, Comparative Genomic Hybridization, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.